Results 291 to 300 of about 5,551,009 (351)
Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy. [PDF]
Mol CancerYan D +6 more
europepmc +1 more source
Drug Delivery Systems for Resiquimod to Control Myeloid-Derived Suppressor Cells in Cancer Immunotherapy. [PDF]
Wiley Interdiscip Rev Nanomed NanobiotechnolHe Y, Yeo Y.
europepmc +1 more source
Exo-nanomaterials in cancer immunotherapy: reprogramming the tumor immune microenvironment. [PDF]
Front ImmunolFang W +5 more
europepmc +1 more source
Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy. [PDF]
Front ImmunolLuo W, Li R, Pan C, Luo C.
europepmc +1 more source
Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring. [PDF]
Front ImmunolZhao WY, Zhao JW.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Clinics of North America: Small Animal Practice, 2009
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
Constantin N, Baxevanis +2 more
openaire +6 more sources
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
Constantin N, Baxevanis +2 more
openaire +6 more sources
Cancer Biotherapy and Radiopharmaceuticals, 2011
Cancer immunotherapy consists of approaches that modify the host immune system, and/or the utilization of components of the immune system, as cancer treatment. During the past 25 years, 17 immunologic products have received regulatory approval based on anticancer activity as single agents and/or in combination with chemotherapy.
Richard L, White, Asim, Amin
openaire +4 more sources
Cancer immunotherapy consists of approaches that modify the host immune system, and/or the utilization of components of the immune system, as cancer treatment. During the past 25 years, 17 immunologic products have received regulatory approval based on anticancer activity as single agents and/or in combination with chemotherapy.
Richard L, White, Asim, Amin
openaire +4 more sources